These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 5593694)

  • 1. [Results of long-term therapy of essential polycythemia using myleran. Definition of criteria for an adequate posology].
    Maurice PA; Alberto P
    Schweiz Med Wochenschr; 1967 Nov; 97(44):1477-8. PubMed ID: 5593694
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of long-term treatment of polycythemia vera with busulfan (Myleran) or dibromomannitol (Myelobromol): analysis of 4 clinical cases observed and treated during more than 7 years].
    Alberto P; Maurice PA
    Praxis; 1969 Sep; 58(38):1211-6. PubMed ID: 4982355
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythropoiesis and erythropoietin in busulphan treated mice.
    Barrio Rendo ME; Alvarez Prado de Tombol ; Scaro JL
    Acta Physiol Lat Am; 1973; 23(5):327-33. PubMed ID: 4784627
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE BLOOD VOLUME IN POLYCYTHEMIA VERA AND ITS CHANGE DURING THERAPY. A CLINICAL CONTRIBUTION TO THE PROBLEM OF BLOOD VOLUME REGULATION].
    BECKER H
    Folia Haematol (Frankf); 1963 Oct; 7():256-90. PubMed ID: 14092679
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of polycythemia with myelosan under ambulatory conditions].
    Krasiukova LI
    Probl Gematol Pereliv Krovi; 1975 May; 20(5):37-40. PubMed ID: 1144332
    [No Abstract]   [Full Text] [Related]  

  • 6. beta 2-Adrenergic stimulation of erythropoiesis in busulfan treated mice.
    Jelkmann W; Bauer C
    Exp Hematol; 1980 Jul; 8(6):742-8. PubMed ID: 7202579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEUROGENIC POLYCYTHEMIA. REPORT OF A PATIENT WITH TRANSIENT ERYTHROCYTOSIS ASSOCIATED WITH OCCLUSION OF A MIDDLE CEREBRAL ARTERY, AND REVIEW OF THE LITERATURE.
    GILBERT HS; SILVERSTEIN A
    Am J Med; 1965 May; 38():807-13. PubMed ID: 14286818
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effect of busulfan in polycythemia].
    Popović K; Stanulovic D
    Med Pregl; 1971; 24(9):479-81. PubMed ID: 5156502
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of haematocrit and red-blood-cell volume in patients with polycythaemia secondary to hypoxic lung disease by dapsone and pyrimethamine.
    Pengelly CD
    Lancet; 1966 Dec; 2(7478):1381-6. PubMed ID: 4163544
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
    Michiels JJ; Berneman Z; Schroyens W; van Urk H
    Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential thrombocythemia following polycythemia vera: an unusual sequence.
    Randi ML; Barbone E; Zerbinati P; Soini B; Rossi C; Girolami A
    J Med; 1996; 27(5-6):363-8. PubMed ID: 9151204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of polycythemia vera with myleran].
    Krykowski E; Wislawska B; Polkowska-Kulesza E
    Przegl Lek; 1965; 21(7):481-3. PubMed ID: 5848465
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of Polycythemia vera and thrombocythemia with myleran (busulphan).
    Epstein IS
    Isr J Med Sci; 1965 Jul; 1(4):797-9. PubMed ID: 5892718
    [No Abstract]   [Full Text] [Related]  

  • 14. [The mechanisms of the erythropoiesis inhibiting action of estrogen hormones].
    Peschle C; Tallarida G; Semprini A; Perroni L; Sasso GF; Condorelli M
    Boll Soc Ital Biol Sper; 1968 Mar; 44(5):344-8. PubMed ID: 5674604
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition by dexamethasone of erythropoietin-induced amplification of the erythropoietin-responsive cell compartment.
    Giglio MJ; Alippi RM; Bozzini CE
    Exp Hematol; 1981 Apr; 9(4):444-8. PubMed ID: 7238657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental thrombocytopenia induced by Busulphan (Myleran) in rabbits: extremely low platelet levels and intact plasma clotting system.
    Evensen SA; Jeremic M; Hjort PF
    Thromb Diath Haemorrh; 1968 Jul; 19(3):570-7. PubMed ID: 5708134
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
    Torregrosa JV; Campistol JM; Montesinos M; Rogada AG; Oppenheimer F; Andreu J
    Transplantation; 1994 Aug; 58(3):311-4. PubMed ID: 8053053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of purified erythropoietin in the amplification of the erythroid compartment.
    Testa NG; Eliason JF; Frassoni F
    Exp Hematol; 1980; 8 Suppl 8():144-52. PubMed ID: 7349636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of polycythemia vera treated with myleran].
    Migdal A
    Wiad Lek; 1966 May; 19(9):737-9. PubMed ID: 5963614
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy against polycythemia due to a cyanotic congenital heart disease in adults. One case report].
    Boussaada R; Békir S; Ben Romdhane N; Mechmèche R
    Tunis Med; 2007 May; 85(5):437-40. PubMed ID: 17657936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.